Mainstream

Biogen, Eisai begin rolling FDA submissions for Leqembi injectable for starting dose

Biogen, Eisai begin rolling FDA submissions for Leqembi injectable for starting dose

Post Contentbiib, esalf, esaiyRead More

You might also be interested in reading EGain targets 20% AI Knowledge ARR growth and expands JPMorgan partnership through 2026.

September 3, 2025
In Mainstream